Oversubscribed Broker Option to raise £100,000

RNS Number : 8528U
Sabien Technology Group PLC
04 August 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310.

4 August 2022

 

Sabien Technology Group plc

("Sabien", the "Company", or the "Group")

Oversubscribed Broker Option Exercised to raise £100,000

 

Sabien Technology Group plc (AIM:SNT), the company focused on a green aggregation strategy, announces that it has conditionally raised a further £100,000 (before expenses) through the exercise of the Broker Option, announced yesterday (defined terms as per that announcement), for 1,000,000 new Ordinary Shares with a number of new and existing investors at a price of 10 pence per Broker Option Share.  The Broker Option was heavily oversubscribed with total orders before scale-back of £515,000.  Investors will receive approximately 19.42% of their application subject to the passing of the resolutions at the forthcoming General Meeting. The exercise of the Broker Option has been arranged by Peterhouse.  The proceeds of the Broker Option will be used for general working capital purposes to execute the Company's green aggregation strategy.

The issue of the 1,000,000 Broker Option Shares is subject to the approval of shareholders at the GM, details of which is expected to be announced later this week.  It is expected that the GM will be held on 22 August 2022.  The Broker Option, a facility to allow existing shareholders to participate in the Company's capital raising on similar terms to the Placing, has now closed and was exercised in respect of the maximum number of new shares available under the option.

An application will be made for the 1,000,000 Broker Option Shares to be admitted to trading on AIM, subject to approval at the GM, which is expected to take effect on or around 23 August 2022, with further details to follow.

Total Voting Rights

Subject to the GM and Admission of the Broker Option Shares, it is anticipated that the Company will have 21,695,168 Ordinary Shares in issue, each with one voting right.  There are no shares held in treasury.  Therefore (subject to the above conditions), the Company's total number of Ordinary Shares and voting rights will be 21,695,168 and this figure may (subject to the above conditions) be used by shareholders from Admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules. 

For Further Information:

Sabien Technology Group plc

Richard Parris, Executive Chairman 

 

 +44 20 7993 3700 

Allenby Capital Limited (Nominated Adviser)

John Depasquale / Nick Harriss / Vivek Bhardwaj 

 

 

+44 203 328 5656

 

Peterhouse Capital Limited (Broker)

Duncan Vasey / Lucy Williams 

 

+44 207 469 0930

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOESSFESDEESESA
UK 100

Latest directors dealings